Carriers of pathogenic variants in BRCA1 have a high risk (approximately > 60%) of developing breast cancer, followed by ovarian cancer (39–58%), and around 5% develop pancreatic cancer. This evidence concerns the gene BRCA1 and ovarian cancer.